Skip to content
Search

Latest Stories

MRPL Expects India to Get Waiver from US Sanctions on Iranian Crude Oil Imports

Mangalore Refinery and Petrochemicals Ltd (MRPL), a major crude oil refinery located in southern India, expects India to get a waiver from US sanctions on Iranian crude oil exports this month, said a company official on the sidelines of the IHS CERA conference on Tuesday (16).

The US is on its way to impose sanctions against Iran’s crude oil sector on November 04 this year in a bid to stop the crude oil producer’s role in conflicts in Syria and Iraq and bring Iran to the negotiating table over its ballistic missile project.


According to a US official earlier this month, US is considering waiver on sanctions for the nations which are cutting their crude oil import from Iran.

India is the second biggest client of Iran after China, that has close relationship with Tehran. India is also constructing a strategic port, Chabahar which may become operational by 2019.

As one of the biggest crude oil importers, India expects of waivers as it moved ahead on qualifying for exceptions known as significant reduction exemptions (SRE) as it is difficult to replace Iranian barrels, the official from MRPL added.

MRPL has already made payments in Indian currency to import crude oil from Iran. However, the official noted the fact that, MRPL would look at buying crude oil from Iraq to replace imports from Iran.

MRPL already has an agreement to purchase 4.5 million tonnes of crude oil from Iran and has imported around 60 to 70 per cent of its contracted volumes till today. According to the agreement, India also has a choice to purchase an additional one million tonnes of crude oil.

India imported around 10 million barrels of crude oil from Iran in October, and its November vessels are likely to move down.

More For You

UK business district
The Canary Wharf business district including global financial institutions in London.
Getty Images

Economy grew 0.7 per cent in Q1 2025, fastest in a year

THE UK economy expanded at its fastest pace in a year during the first quarter of 2025, driven by a rise in home purchases ahead of a tax deadline and higher manufacturing output before the introduction of new US import tariffs.

Gross domestic product rose by 0.7 per cent in the January-to-March period, the Office for National Statistics (ONS) said, confirming its earlier estimate. This was the strongest quarterly growth since the first quarter of 2024.

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less